Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhong-Quan Sun

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Zhonghua Nan Ke Xue = National Journal of Andrology|September 9, 2014
[Updated relationship between testosterone and prostate cancer]Zhong-Quan Sun, Zhi-Yuan Shen
Asian Pacific Journal of Cancer Prevention : APJCP|May 13, 2014
TMPRSS2:ETS fusions and clinicopathologic characteristics of prostate cancer patients from Eastern ChinaJun Dong, Li Xiao, Lu Sheng, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|July 13, 2005
[The study of diagnosis and treatment of interstitial cystitis]Zhong-quan Sun, Wei-qing Qian, Dan-sheng Xie, et al.
Photomedicine and Laser Surgery|September 7, 2016
Treatment of Ureteral Fibroepithelial Polyp by Ureteroscopy Combined with Holmium Laser or Thulium Laser: A Retrospective StudyLu Sheng, Zhong-Yun Zhang, Wei-Qing Qian, et al.
Urology Case Reports|June 18, 2016
Acute Abdominal Compartment Syndrome as a Complication of Percutaneous Nephrolithotomy: Two Cases Reports and Literature ReviewJing Tao, Lu Sheng, Hao-Jie Zhang, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|January 6, 2015
New therapeutic schedule for prostatic cancer-3 cells with ET-1 RNAi and EndostarHao-Jie Zhang, Wei-Qing Qian, Ran Chen, et al.
International Journal of Surgery Case Reports|January 31, 2012
Contralateral ureteral metastasis 4 years after radical nephrectomyHao-Jie Zhang, Lu Sheng, Zhen-Wang Zhang, et al.
BMC Medicine|July 1, 2026
Impact of hepatotoxicity and lipid metabolism-related toxicity on survival and quality of life in patients with high-volume metastatic hormone-sensitive prostate cancer treated with rezvilutamide in the CHART trial: a post hoc analysisJun-Long Wu, Shu-Suan Jiang, Hong Luo, et al.
Asian Journal of Andrology|May 1, 2015
Percent free prostate-specific antigen is effective to predict prostate biopsy outcome in Chinese men with prostate-specific antigen between 10.1 and 20.0 ng ml(-1)Rui Chen, Li-Qun Zhou, Xiao-Bing Cai, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Zhonghua Nan Ke Xue = National Journal of Andrology|September 9, 2014
[Updated relationship between testosterone and prostate cancer]Zhong-Quan Sun, Zhi-Yuan Shen
Asian Pacific Journal of Cancer Prevention : APJCP|May 13, 2014
TMPRSS2:ETS fusions and clinicopathologic characteristics of prostate cancer patients from Eastern ChinaJun Dong, Li Xiao, Lu Sheng, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|July 13, 2005
[The study of diagnosis and treatment of interstitial cystitis]Zhong-quan Sun, Wei-qing Qian, Dan-sheng Xie, et al.
Photomedicine and Laser Surgery|September 7, 2016
Treatment of Ureteral Fibroepithelial Polyp by Ureteroscopy Combined with Holmium Laser or Thulium Laser: A Retrospective StudyLu Sheng, Zhong-Yun Zhang, Wei-Qing Qian, et al.
Urology Case Reports|June 18, 2016
Acute Abdominal Compartment Syndrome as a Complication of Percutaneous Nephrolithotomy: Two Cases Reports and Literature ReviewJing Tao, Lu Sheng, Hao-Jie Zhang, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|January 6, 2015
New therapeutic schedule for prostatic cancer-3 cells with ET-1 RNAi and EndostarHao-Jie Zhang, Wei-Qing Qian, Ran Chen, et al.
International Journal of Surgery Case Reports|January 31, 2012
Contralateral ureteral metastasis 4 years after radical nephrectomyHao-Jie Zhang, Lu Sheng, Zhen-Wang Zhang, et al.
BMC Medicine|July 1, 2026
Impact of hepatotoxicity and lipid metabolism-related toxicity on survival and quality of life in patients with high-volume metastatic hormone-sensitive prostate cancer treated with rezvilutamide in the CHART trial: a post hoc analysisJun-Long Wu, Shu-Suan Jiang, Hong Luo, et al.
Asian Journal of Andrology|May 1, 2015
Percent free prostate-specific antigen is effective to predict prostate biopsy outcome in Chinese men with prostate-specific antigen between 10.1 and 20.0 ng ml(-1)Rui Chen, Li-Qun Zhou, Xiao-Bing Cai, et al.
Pageof 1